Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Evotec SE (EVOTF) Cost of Revenue (2019 - 2025)

Historic Cost of Revenue for Evotec SE (EVOTF) over the last 9 years, with Q3 2025 value amounting to $191665.4.

  • Evotec SE's Cost of Revenue rose 475.18% to $191665.4 in Q3 2025 from the same period last year, while for Sep 2025 it was $728.9 million, marking a year-over-year increase of 7083880.18%. This contributed to the annual value of $728.9 million for FY2024, which is 1171.8% up from last year.
  • As of Q3 2025, Evotec SE's Cost of Revenue stood at $191665.4, which was up 475.18% from $728.3 million recorded in Q4 2024.
  • Evotec SE's 5-year Cost of Revenue high stood at $728.3 million for Q4 2024, and its period low was $123525.8 during Q1 2021.
  • Moreover, its 5-year median value for Cost of Revenue was $175832.6 (2023), whereas its average is $45.7 million.
  • As far as peak fluctuations go, Evotec SE's Cost of Revenue tumbled by 9988.27% in 2021, and later soared by 15279860.03% in 2024.
  • Quarter analysis of 5 years shows Evotec SE's Cost of Revenue stood at $379219.6 in 2021, then rose by 12.77% to $427636.7 in 2022, then grew by 11.39% to $476349.8 in 2023, then surged by 152798.6% to $728.3 million in 2024, then crashed by 99.97% to $191665.4 in 2025.
  • Its last three reported values are $191665.4 in Q3 2025, $728.3 million for Q4 2024, and $182971.1 during Q3 2024.